Jazz Pharmaceuticals
JAZZ
#1410
Rank
A$22.28 B
Marketcap
A$347.23
Share price
-2.62%
Change (1 day)
27.98%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): A$5.45

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$5.47. In 2025 the company made an earnings per share (EPS) of A-$8.73 a decrease over its 2024 EPS that were of A$13.74.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.45-162.41%
2025A-$8.73-163.56%
2024A$13.7439.08%
2023A$9.88-285.03%
2022A-$5.34-34.2%
2021A-$8.11-224.83%
2020A$6.50-53.25%
2019A$13.9023.59%
2018A$11.25-8.24%
2017A$12.2623.74%
2016A$9.9122.12%
2015A$8.11478.49%
2014A$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.92 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$12.50 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
A-$1.61-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$0.68-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel